Bicycle Therapeutics plc - Depositary Receipt (Common Stock) - Laporan Laba Rugi (TTM)

Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
US ˙ NasdaqGS ˙ US0887861088

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Bicycle Therapeutics plc - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 12 10 11 11 12 12 14 16 15 14 15 23 25 27 42 40 37 35 26 19
Change (%) -12.12 6.54 1.93 4.35 -0.65 17.54 18.86 -7.91 -3.89 7.16 45.29 10.27 8.64 54.25 -4.89 -6.76 -4.40 -27.08 -25.04
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 30 33 35 38 41 45 49 56 67 82 98 117 134 156 159 164 172 173 197 228
Change (%) 11.46 5.79 9.17 7.20 9.36 8.47 14.64 20.24 21.62 20.26 19.21 14.32 17.01 1.87 3.03 4.55 0.72 14.06 15.63
% of Revenue 251.54 319.05 316.81 339.30 348.56 383.69 354.07 341.49 445.87 564.26 633.20 519.53 538.65 580.13 383.12 415.05 465.42 490.34 767.01 1,183.19
Gross Operating Profit -18 -23 -24 -27 -29 -33 -35 -39 -52 -67 -83 -94 -109 -130 -118 -125 -135 -138 -172 -209
Change (%) 27.02 5.45 12.50 8.39 13.38 5.27 12.97 31.89 29.00 23.08 14.32 15.29 18.92 -9.04 5.83 8.14 2.12 24.60 21.73
% of Revenue -151.54 -219.05 -216.81 -239.30 -248.56 -283.69 -254.07 -241.49 -345.87 -464.26 -533.20 -419.53 -438.65 -480.13 -283.12 -315.05 -365.42 -390.34 -667.01 -1,083.19
SG&A 22 29 32 34 35 32 42 48 50 50 48 52 59 60 62 59 62 72 77 79
Change (%) 34.28 10.76 5.24 3.97 -8.34 29.63 13.06 6.06 -1.80 -2.17 8.22 12.58 2.41 2.69 -5.37 4.93 17.15 6.39 3.48
% of Revenue 183.94 281.05 292.19 301.66 300.56 277.29 305.80 290.88 335.01 342.30 312.49 232.76 237.64 224.00 149.13 148.37 166.98 204.62 298.54 412.15
R&D
Change (%)
% of Revenue
OpEx 51 62 67 72 76 77 91 103 118 131 147 169 193 217 221 223 233 245 274 308
Change (%) 21.10 8.12 7.28 5.68 1.16 17.35 13.91 13.71 11.57 11.79 15.58 13.78 12.54 2.10 0.68 4.65 5.06 11.80 12.23
% of Revenue 435.48 600.10 609.00 640.96 649.13 660.98 659.87 632.37 780.88 906.56 945.69 752.30 776.29 804.13 532.25 563.42 632.40 694.96 1,065.55 1,595.33
Operating Income -40 -52 -56 -61 -65 -66 -77 -87 -102 -117 -131 -147 -168 -190 -180 -183 -196 -210 -248 -288
Change (%) 31.00 8.43 8.33 5.93 1.49 17.31 13.02 17.78 13.85 12.36 12.06 14.32 13.12 -5.31 1.97 7.12 6.84 18.34 16.09
% of Revenue -335.48 -500.10 -509.00 -540.96 -549.13 -560.98 -559.87 -532.37 -680.88 -806.56 -845.69 -652.30 -676.29 -704.13 -432.25 -463.42 -532.40 -594.96 -965.55 -1,495.33
Interest Expense -0 -1 -2 -3 -3 -3 -3 -3 -3 -3 -3 -3 -3 -3 -3 -2 -2 -1 -0
Change (%) 114.22 83.66 45.77 13.85 9.92 1.95 -0.18 0.18 -0.30 -1.86 -0.09 -0.18 0.40 0.09 -23.82 -30.74 -44.51 -80.21
% of Revenue -4.40 -8.84 -15.94 -22.26 -25.51 -23.86 -20.46 -22.18 -23.12 -21.51 -14.53 -13.17 -12.10 -7.87 -8.29 -6.77 -4.90 -3.73 -0.99
Net Income -38 -51 -56 -62 -66 -67 -78 -87 -101 -113 -124 -140 -162 -181 -168 -165 -166 -169 -203 -242
Change (%) 34.30 9.54 10.38 7.36 0.91 17.02 11.40 15.69 11.85 10.20 12.70 15.39 11.84 -6.92 -1.66 0.55 1.66 20.23 19.26
% of Revenue -321.26 -490.95 -504.81 -546.63 -562.38 -571.25 -568.71 -533.03 -669.65 -779.35 -801.45 -621.69 -650.60 -669.72 -404.14 -417.88 -450.64 -479.18 -790.07 -1,257.00

Source: Capital IQ

Other Listings
DE:50BA € 5.95
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista